<code id='981ECBC71B'></code><style id='981ECBC71B'></style>
    • <acronym id='981ECBC71B'></acronym>
      <center id='981ECBC71B'><center id='981ECBC71B'><tfoot id='981ECBC71B'></tfoot></center><abbr id='981ECBC71B'><dir id='981ECBC71B'><tfoot id='981ECBC71B'></tfoot><noframes id='981ECBC71B'>

    • <optgroup id='981ECBC71B'><strike id='981ECBC71B'><sup id='981ECBC71B'></sup></strike><code id='981ECBC71B'></code></optgroup>
        1. <b id='981ECBC71B'><label id='981ECBC71B'><select id='981ECBC71B'><dt id='981ECBC71B'><span id='981ECBC71B'></span></dt></select></label></b><u id='981ECBC71B'></u>
          <i id='981ECBC71B'><strike id='981ECBC71B'><tt id='981ECBC71B'><pre id='981ECBC71B'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:7326
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Merck drug for rare lung condition set for approval in U.S.
          Merck drug for rare lung condition set for approval in U.S.

          AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Free Covid tests will again be offered to all U.S. households

          AdobeThefederalgovernmentisagainofferingfreeCovid-19teststoAmericans,providingafifthroundoffreetests